What is Eikon Therapeutics, Inc. 's interest paid?

Eikon Therapeutics, Inc. (EIKN) reported interest paid of $4K in Q1 2026.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

MYR GroupMYRG

$1.28M-11.1%

Cabot CorporationCBT

$19.75M-3.7%

UnifirstUNF

$287.5K-1.6%

Main Street CapitalMAIN

$42.19M+28.1%

NNN REITNNN

$18.75M+1,920%

Dave, Inc.DAVE

$1.61M-7.1%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's interest paid?: Eikon Therapeutics, Inc. (EIKN) reported interest paid of $4K in Q1 2026.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.